Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
DexCom Analyst Ratings and Price Targets | NASDAQ:DXCM | Benzinga
DexCom Inc has a consensus price target of $104.69 based on the ratings of 26 analysts. The high is $150 issued by Canaccord Genuity on July 28, 2023. The low is $82 issued by Morgan Stanley on February 14, 2025. The 3 most-recent analyst ratings were released by Truist Securities, Goldman Sachs, and Citigroup on June 16, 2025, May 30, 2025, and May 22, 2025, respectively. With an average price target of $102.67 between Truist Securities, Goldman Sachs, and Citigroup, there's an implied 25.45% upside for DexCom Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Goldman Sachs
Citigroup
Barclays
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for DexCom
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/16/2025 | Buy Now | 24.63% | Truist Securities | Richard Newitter73% | → $102 | Initiates | → Buy | Get Alert |
| 05/30/2025 | Buy Now | 27.08% | Goldman Sachs | Kate McShane67% | → $104 | Initiates | → Buy | Get Alert |
| 05/22/2025 | Buy Now | 24.63% | Citigroup | Joanne Wuensch74% | $82 → $102 | Maintains | Buy | Get Alert |
| 05/05/2025 | Buy Now | 13.64% | Barclays | Matt Miksic65% | $90 → $93 | Maintains | Equal-Weight | Get Alert |
| 05/02/2025 | Buy Now | 29.52% | Canaccord Genuity | William Plovanic59% | $103 → $106 | Maintains | Buy | Get Alert |
| 05/02/2025 | Buy Now | 9.97% | Piper Sandler | Matt O'Brien52% | $100 → $90 | Maintains | Overweight | Get Alert |
| 05/02/2025 | Buy Now | 28.3% | Baird | Jeff Johnson76% | $115 → $105 | Maintains | Outperform | Get Alert |
| 04/10/2025 | Buy Now | 3.86% | Mizuho | Anthony Petrone64% | → $85 | Initiates | → Outperform | Get Alert |
| 03/04/2025 | Buy Now | 27.08% | Citigroup | Joanne Wuensch74% | $101 → $104 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 25.86% | Canaccord Genuity | William Plovanic59% | $99 → $103 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 0.2% | Morgan Stanley | Patrick Wood49% | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | 40.52% | Redburn Atlantic | Issie Kirby30% | $85 → $115 | Upgrade | Neutral → Buy | Get Alert |
| 01/16/2025 | Buy Now | 27.08% | Baird | Jeff Johnson76% | $86 → $104 | Upgrade | Neutral → Outperform | Get Alert |
| 12/11/2024 | Buy Now | 11.19% | Citigroup | Joanne Wuensch74% | $85 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 14.86% | Wells Fargo | Larry Biegelsen65% | $90 → $94 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 20.97% | Canaccord Genuity | William Plovanic59% | $89 → $99 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 5.08% | Bernstein | Lee Hambright69% | $82 → $86 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 20.97% | Raymond James | Jayson Bedford67% | $115 → $99 | Maintains | Strong Buy | Get Alert |
| 10/25/2024 | Buy Now | 40.52% | RBC Capital | Shagun Singh57% | $120 → $115 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 28.3% | Oppenheimer | Steven Lichtman62% | $115 → $105 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 3.86% | JP Morgan | Robbie Marcus65% | $75 → $85 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | 6.3% | Leerink Partners | Mike Kratky66% | $90 → $87 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 9.97% | Wells Fargo | Larry Biegelsen65% | $80 → $90 | Maintains | Overweight | Get Alert |
| 10/08/2024 | Buy Now | 46.63% | RBC Capital | Shagun Singh57% | $130 → $120 | Maintains | Outperform | Get Alert |
| 08/26/2024 | Buy Now | 9.97% | Piper Sandler | Matt O'Brien52% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 08/23/2024 | Buy Now | 22.19% | Stifel | Mathew Blackman61% | $90 → $100 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 0.2% | Baird | Jeff Johnson76% | $80 → $82 | Maintains | Neutral | Get Alert |
| 07/29/2024 | Buy Now | 38.07% | Barclays | Matt Miksic65% | $138 → $113 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | -2.25% | Baird | Jeff Johnson76% | $161 → $80 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2024 | Buy Now | 46.63% | BTIG | Marie Thibault62% | $156 → $120 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -8.36% | Morgan Stanley | Patrick Wood49% | $120 → $75 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 40.52% | Oppenheimer | Steven Lichtman62% | $150 → $115 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 16.08% | UBS | Danielle Antalffy61% | $163 → $95 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 9.97% | Stifel | Mathew Blackman61% | $132 → $90 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 9.97% | Piper Sandler | Matt O'Brien52% | $150 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 77.17% | RBC Capital | Shagun Singh57% | $165 → $145 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | -2.25% | Wells Fargo | Larry Biegelsen65% | $145 → $80 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 8.75% | Canaccord Genuity | William Plovanic59% | $145 → $89 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -8.36% | JP Morgan | Robbie Marcus65% | $145 → $75 | Downgrade | Overweight → Neutral | Get Alert |
| 07/23/2024 | Buy Now | 77.17% | Canaccord Genuity | William Plovanic59% | $145 → $145 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 46.63% | Morgan Stanley | Patrick Wood49% | $132 → $120 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 61.29% | Stifel | Mathew Blackman61% | $145 → $132 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 58.85% | Redburn Atlantic | Issie Kirby30% | → $130 | Initiates | → Neutral | Get Alert |
| 04/26/2024 | Buy Now | 95.5% | Raymond James | Jayson Bedford67% | $151 → $160 | Maintains | Strong Buy | Get Alert |
| 04/26/2024 | Buy Now | 77.17% | Canaccord Genuity | William Plovanic59% | $144 → $145 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 99.17% | UBS | Danielle Antalffy61% | $153 → $163 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 96.73% | Citigroup | Joanne Wuensch74% | $148 → $161 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 101.61% | RBC Capital | Shagun Singh57% | → $165 | Initiates | → Outperform | Get Alert |
| 01/23/2024 | Buy Now | 84.51% | Raymond James | Jayson Bedford67% | $147 → $151 | Maintains | Strong Buy | Get Alert |
| 01/03/2024 | Buy Now | 79.62% | Raymond James | Jayson Bedford67% | $131 → $147 | Maintains | Strong Buy | Get Alert |
| 12/19/2023 | Buy Now | 83.28% | Piper Sandler | Matt O'Brien52% | $135 → $150 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 66.18% | Wells Fargo | Larry Biegelsen65% | $110 → $136 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | 49.07% | Morgan Stanley | Patrick Wood49% | $101 → $122 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | 23.41% | Morgan Stanley | Patrick Wood49% | $98 → $101 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 22.19% | JP Morgan | Michael Weinstein74% | $160 → $100 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 34.41% | Leerink Partners | Mike Kratky66% | → $110 | Initiates | → Outperform | Get Alert |
| 10/10/2023 | Buy Now | 77.17% | Stifel | Mathew Blackman61% | $155 → $145 | Maintains | Buy | Get Alert |
| 09/29/2023 | Buy Now | 19.75% | Morgan Stanley | Patrick Wood49% | $131 → $98 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | 60.07% | Raymond James | Jayson Bedford67% | $154 → $131 | Maintains | Strong Buy | Get Alert |
| 09/06/2023 | Buy Now | 68.62% | UBS | Danielle Antalffy61% | $175 → $138 | Maintains | Buy | Get Alert |
| 08/21/2023 | Buy Now | 58.85% | Baird | Jeff Johnson76% | $153 → $130 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 68.62% | Barclays | Matt Miksic65% | $115 → $138 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 95.5% | Piper Sandler | Matt O'Brien52% | $150 → $160 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 83.28% | Canaccord Genuity | Kyle Rose68% | $135 → $150 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 88.17% | Raymond James | Jayson Bedford67% | $140 → $154 | Maintains | Strong Buy | Get Alert |
| 07/28/2023 | Buy Now | 86.95% | Baird | Jeff Johnson76% | $145 → $153 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 83.28% | Citigroup | Joanne Wuensch74% | $146 → $150 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 83.28% | BTIG | Marie Thibault62% | $134 → $150 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 60.07% | Morgan Stanley | Patrick Wood49% | → $131 | Assumes | → Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | 40.52% | Barclays | Matt Miksic65% | $110 → $115 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 71.07% | Stifel | Mathew Blackman61% | $130 → $140 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 63.73% | BTIG | Marie Thibault62% | $132 → $134 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 64.96% | Canaccord Genuity | Kyle Rose68% | $125 → $135 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 71.07% | Raymond James | Jayson Bedford67% | $138 → $140 | Maintains | Strong Buy | Get Alert |
| 04/17/2023 | Buy Now | 61.29% | BTIG | Marie Thibault62% | $126 → $132 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 68.62% | Raymond James | Jayson Bedford67% | $127 → $138 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/29/2023 | Buy Now | 73.51% | UBS | Danielle Antalffy61% | → $142 | Initiates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | 34.41% | Barclays | Matt Miksic65% | $103 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 52.74% | Cowen & Co. | Joshua Jennings57% | $114 → $125 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 47.85% | Wolfe Research | Mike Polark55% | → $121 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | Buy Now | 60.07% | Morgan Stanley | Cecilia Furlong50% | $117 → $131 | Maintains | Equal-Weight | Get Alert |
| 12/12/2022 | Buy Now | 78.4% | Citigroup | Joanne Wuensch74% | $117 → $146 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 42.96% | Morgan Stanley | Cecilia Furlong50% | $107 → $117 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 56.4% | Wells Fargo | Larry Biegelsen65% | $102 → $128 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 52.74% | Raymond James | Jayson Bedford67% | $101 → $125 | Maintains | Outperform | Get Alert |
| 10/18/2022 | Buy Now | 25.86% | Barclays | Matt Miksic65% | → $103 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 52.74% | Jefferies | Matthew Taylor70% | → $125 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 30.74% | Morgan Stanley | Cecilia Furlong50% | $83 → $107 | Maintains | Equal-Weight | Get Alert |
| 10/10/2022 | Buy Now | 34.41% | BTIG | Marie Thibault62% | $92 → $110 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 46.63% | Stifel | Mathew Blackman61% | $112 → $120 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 46.63% | Piper Sandler | Matt O'Brien52% | $110 → $120 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 23.41% | Raymond James | Jayson Bedford67% | $122 → $101 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | 1.42% | Morgan Stanley | Cecilia Furlong50% | $91 → $83 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | 34.41% | Piper Sandler | Matt O'Brien52% | $120 → $110 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 28.3% | Bernstein | Lee Hambright69% | → $105 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | Buy Now | 28.3% | BTIG | Marie Thibault62% | $135 → $105 | Maintains | Buy | Get Alert |
FAQ
What is the target price for DexCom (DXCM) stock?
The latest price target for DexCom (NASDAQ:DXCM) was reported by Truist Securities on June 16, 2025. The analyst firm set a price target for $102.00 expecting DXCM to rise to within 12 months (a possible 24.63% upside). 42 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DexCom (DXCM)?
The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Truist Securities, and DexCom initiated their buy rating.
When was the last upgrade for DexCom (DXCM)?
The last upgrade for DexCom Inc happened on February 3, 2025 when Redburn Atlantic raised their price target to $115. Redburn Atlantic previously had a neutral for DexCom Inc.
When was the last downgrade for DexCom (DXCM)?
The last downgrade for DexCom Inc happened on July 26, 2024 when Baird changed their price target from $161 to $80 for DexCom Inc.
When is the next analyst rating going to be posted or updated for DexCom (DXCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on June 16, 2025 so you should expect the next rating to be made available sometime around June 16, 2026.
Is the Analyst Rating DexCom (DXCM) correct?
While ratings are subjective and will change, the latest DexCom (DXCM) rating was a initiated with a price target of $0.00 to $102.00. The current price DexCom (DXCM) is trading at is $81.84, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
